Liang, X., Dai, J., & Wang, F. Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: A meta-analysis. BMC.
Chicago Style (17th ed.) CitationLiang, Xiaoyan, Jianghong Dai, and Feifei Wang. Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and the Risk of Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: A Meta-analysis. BMC.
MLA (9th ed.) CitationLiang, Xiaoyan, et al. Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and the Risk of Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: A Meta-analysis. BMC.
Warning: These citations may not always be 100% accurate.